• Mon, December 23, 2019
  • Tue, December 24, 2019
  • Thu, December 26, 2019
  • Fri, December 27, 2019
  • Mon, December 30, 2019
  • Thu, January 2, 2020
  • Tue, December 31, 2019

Brian Abrahams Maintained (SRPT) at Buy with Decreased Target to $200 on, Dec 23rd, 2019

Brian Abrahams of RBC Capital, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $215 to $200 on, Dec 23rd, 2019.

Brian has made no other calls on SRPT in the last 4 months.



There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 0 agree with Brian's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Brian


  • Brian Skorney of "Baird" Maintained at Buy with Increased Target to $192 on, Friday, December 20th, 2019
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $211 on, Friday, December 13th, 2019
  • Yun Zhong of "Janney Montgomery Scott" Maintained at Strong Buy with Increased Target to $175 on, Friday, December 13th, 2019
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $167 on, Monday, November 18th, 2019
  • Whitney Ijem of "Guggenheim" Initiated at Strong Buy and Held Target at $183 on, Friday, November 1st, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $160 on, Friday, October 11th, 2019